Keyphrases
Alzheimer's Disease
20%
Amyotrophic Lateral Sclerosis
20%
Anti-neuroinflammation
20%
Autoreactive
20%
Central Nervous System
20%
Central Nervous System Injury
20%
Central Nervous System Repair
20%
Clinical Setting
20%
Demyelination
20%
Disease Class
20%
Disease-modifying Therapy
20%
Drug Development Strategy
20%
Foreign Antigen
20%
Germ Cells
40%
High Incidence
20%
High Potency
20%
Human Disease
20%
Immune System
20%
Inflammation
20%
Inhibitory Microenvironment
20%
Insults
20%
Irreversible Damage
20%
Ischemia
20%
Lack of Efficacy
20%
Long-term Disability
20%
Multiple Sclerosis
40%
Naturally Occurring Antibodies
100%
Neurodegeneration
20%
Neurodegenerative Diseases
20%
Neurologic Disorders
60%
Neurological Diseases
100%
Neuroprotective Treatment
20%
Neuroregenerative
20%
Novel Therapeutics
20%
Oligodendrocyte
40%
Parkinson's Disease
20%
Peer-reviewed Articles
20%
Phase 1 Clinical Trial
20%
Physiological Function
20%
Prospective Randomized Clinical Trial
20%
PubMed Search
20%
Recombinant
40%
Regeneration
20%
Retrospective Review
20%
Targeted Drug Development
20%
Therapeutic Agents
60%
Therapeutic Potential
100%
Toxic Effects
60%
Trauma
20%
Treatment Strategy
20%
Neuroscience
Alzheimer's Disease
33%
Amyotrophic Lateral Sclerosis
33%
Central Nervous System
100%
Germ Cell
66%
Immunoglobulin A
33%
Ischemia
33%
Multiple Sclerosis
66%
Nervous System Disorder
100%
Neurodegeneration
33%
Neurodegenerative Disorder
33%
Neuroprotective Agent
33%
Oligodendrocyte
66%
Parkinson's Disease
33%
Remyelinization
33%
Medicine and Dentistry
Alzheimer's Disease
20%
Amyotrophic Lateral Sclerosis
20%
Central Nervous System
60%
Clinical Trial
20%
Degenerative Disease
20%
Disease Modifying Therapy
20%
Diseases
20%
Germ Cell
40%
Immune System
20%
Immunoglobulin A
20%
Infection
20%
Ischemia
20%
Multiple Sclerosis
40%
Nervous System Injury
20%
Neurodegeneration
20%
Neurologic Disease
100%
Neuroprotective Agent
20%
Oligodendrocyte
40%
Parkinson's Disease
20%
Randomized Clinical Trial
20%
Regeneration
20%
Remyelination
20%
Therapeutic Agent
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
20%
Amyotrophic Lateral Sclerosis
20%
Clinical Trial
20%
Degenerative Disease
20%
Diseases
40%
Drug Development
20%
Immunoglobulin A
20%
Infection
20%
Inflammation
20%
Ischemia
20%
Multiple Sclerosis
40%
Nerve Degeneration
20%
Nervous System Injury
20%
Neurologic Disease
100%
Neuroprotective Agent
20%
Parkinson's Disease
20%
Randomized Clinical Trial
20%